Yosuke Tsuji Selected Research

Pathologic Constriction (Stenosis)

1/2023	Repeated steroid injection and polyglycolic acid shielding for prevention of refractory esophageal stricture.
12/2020	Steroid injection and polyglycolic acid shielding to prevent stricture after esophageal endoscopic submucosal dissection: a retrospective comparative analysis (with video).
4/2019	Management of adverse events related to endoscopic resection of upper gastrointestinal neoplasms: Review of the literature and recommendations from experts.
1/2016	Triamcinolone Injection and Shielding with Polyglycolic Acid Sheets and Fibrin Glue for Postoperative Stricture Prevention after Esophageal Endoscopic Resection: A Pilot Study.
4/2015	Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yosuke Tsuji Research Topics

Disease

15	Stomach Neoplasms (Stomach Cancer) 11/2023 - 01/2011
15	Hemorrhage 09/2023 - 08/2010
10	Neoplasms (Cancer) 09/2023 - 01/2014
6	Ulcer 01/2022 - 01/2014
5	Esophageal Stenosis (Esophageal Stricture) 10/2023 - 01/2015
5	Adenoma (Adenomas) 07/2023 - 10/2012
5	Pathologic Constriction (Stenosis) 01/2023 - 04/2015
4	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 06/2020
3	Sarcopenia 01/2024 - 01/2022
3	Thromboembolism 01/2023 - 01/2021
3	Carcinoma (Carcinomatosis) 01/2023 - 08/2010
3	Chronic Renal Insufficiency 10/2021 - 04/2019
3	Atrophic Gastritis 07/2016 - 01/2014
3	Infections 04/2016 - 01/2013
2	Adenocarcinoma 01/2023 - 01/2022
2	Gastroesophageal Reflux (GERD) 01/2022 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 10/2021
2	Esophageal Neoplasms (Esophageal Cancer) 12/2020 - 01/2016
2	Diverticulum 01/2019 - 01/2015
2	Heartburn (Pyrosis) 01/2014 - 01/2013
1	Inflammation (Inflammations) 04/2024
1	Necrosis 04/2024
1	Colitis 04/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024
1	Body Weight Changes 10/2023
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Polyps 11/2022
1	Hiatal Hernia 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Bile Reflux 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021
1	Atrophy 08/2021
1	Gastritis 08/2021
1	Carcinogenesis 07/2021
1	COVID-19 01/2021
1	Stomach Ulcer (Gastric Ulcer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Peptic Esophagitis (Reflux Esophagitis) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018

Drug/Important Bio-Agent (IBA)

9	Polyglycolic Acid (Polyglycolide)IBA 01/2023 - 01/2014
7	Warfarin (Coumadin)FDA LinkGeneric 09/2023 - 05/2014
7	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 04/2019 - 01/2014
6	AnticoagulantsIBA 09/2023 - 04/2019
6	Prostaglandins AIBA 01/2023 - 01/2014
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2022 - 07/2012
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 05/2014
5	SteroidsIBA 01/2023 - 01/2015
4	Pepsinogen A (Pepsinogen)IBA 03/2023 - 01/2013
4	Proton Pump InhibitorsIBA 01/2022 - 01/2014
4	BariumIBA 08/2021 - 01/2014
3	Indicators and Reagents (Reagents)IBA 07/2023 - 06/2020
3	Cilostazol (Pletal)FDA LinkGeneric 01/2023 - 01/2021
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2014
3	AcidsIBA 07/2016 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 05/2021
2	thienopyridineIBA 01/2023 - 10/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 10/2021
2	Purinergic P2Y Receptor AntagonistsIBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 04/2016 - 01/2014
1	EnzymesIBA 04/2024
1	PowdersIBA 10/2023
1	GelatinIBA 10/2023
1	AlginatesIBA 10/2023
1	Thyroid Nuclear Factor 1IBA 01/2023
1	imidazoleacetic acid (IMAC)IBA 12/2022
1	Calcibiotic Root Canal SealerIBA 11/2022
1	ORALIT (ORS)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2021
1	RNA (Ribonucleic Acid)IBA 05/2021
1	Phenobarbital (Luminal)FDA Link 02/2021
1	Dabigatran FDA Link 01/2021
1	HydrogelsIBA 01/2021
1	Factor Xa InhibitorsIBA 01/2021
1	Coloring Agents (Dyes)IBA 10/2020
1	Carmine (Natural Red 4)IBA 10/2020
1	Heparin (Liquaemin)FDA LinkGeneric 04/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	APTIBA 10/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018

Therapy/Procedure

7	Therapeutics 01/2024 - 01/2018
3	Chemoprevention 11/2022 - 07/2021
2	Length of Stay 01/2024 - 01/2022
2	Colonoscopes 11/2022 - 06/2020
2	Renal Dialysis (Hemodialysis) 10/2021 - 01/2021
2	Traction 02/2021 - 01/2019
2	Endoscopic Hemostasis 01/2021 - 07/2016
1	Decompression 04/2024
1	Colectomy 04/2024
1	Ligation 02/2024
1	Palliative Care (Palliative Therapy) 11/2023
1	Gastrectomy 11/2023
1	Drug Therapy (Chemotherapy) 12/2022
1	Injections 01/2021
1	Personal Protective Equipment 01/2021
1	Eye Protective Devices (Goggles) 01/2021
1	N95 Respirators 01/2021
1	Perioperative Period 01/2021
1	Self Expandable Metallic Stents 04/2019